BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 11067918)

  • 1. TNF regulates thymocyte production by apoptosis and proliferation of the triple negative (CD3-CD4-CD8-) subset.
    Baseta JG; Stutman O
    J Immunol; 2000 Nov; 165(10):5621-30. PubMed ID: 11067918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha is the critical mediator of the cyclic AMP-induced apoptosis of CD8+4+ double-positive thymocytes.
    Guevara Patiño JA; Ivanov VN; Lacy E; Elkon KB; Marino MW; Nikolic-Zugić J
    J Immunol; 2000 Feb; 164(4):1689-94. PubMed ID: 10657611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice.
    Heinly CS; Sempowski GD; Lee DM; Patel DD; McDermott PM; Scearce RM; Thompson CB; Haynes BF
    Int Immunol; 2001 Feb; 13(2):157-66. PubMed ID: 11157849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity.
    Hill GR; Teshima T; Rebel VI; Krijanovski OI; Cooke KR; Brinson YS; Ferrara JL
    J Immunol; 2000 Jan; 164(2):656-63. PubMed ID: 10623807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Il-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice.
    Andrew D; Aspinall R
    J Immunol; 2001 Feb; 166(3):1524-30. PubMed ID: 11160192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro induction of CD8 expression on thymic pre-T cells. I. Transforming growth factor-beta and tumor necrosis factor-alpha induce CD8 expression on CD8- thymic subsets including the CD25+CD3-CD4-CD8- pre-T cell subset.
    Suda T; Zlotnik A
    J Immunol; 1992 Mar; 148(6):1737-45. PubMed ID: 1347307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death.
    Teh HS; Seebaran A; Teh SJ
    J Immunol; 2000 Nov; 165(9):4814-21. PubMed ID: 11046004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early growth response gene 3 regulates thymocyte proliferation during the transition from CD4-CD8- to CD4+CD8+.
    Xi H; Kersh GJ
    J Immunol; 2004 Jan; 172(2):964-71. PubMed ID: 14707069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro induction of CD8 expression on thymic pre-T cells. II. Characterization of CD3-CD4-CD8 alpha + cells generated in vitro by culturing CD25+CD3-CD4-CD8- thymocytes with T cell growth factor-beta and tumor necrosis factor-alpha.
    Suda T; Zlotnik A
    J Immunol; 1992 Jul; 149(1):71-6. PubMed ID: 1607663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIGHT (a cellular ligand for herpes virus entry mediator and lymphotoxin receptor)-mediated thymocyte deletion is dependent on the interaction between TCR and MHC/self-peptide.
    Wang J; Fu YX
    J Immunol; 2003 Apr; 170(8):3986-93. PubMed ID: 12682226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferons alpha/beta inhibit IL-7-induced proliferation of CD4- CD8- CD3- CD44+ CD25+ thymocytes, but do not inhibit that of CD4- CD8- CD3- CD44- CD25- thymocytes.
    Su DM; Wang J; Lin Q; Cooper MD; Watanabe T
    Immunology; 1997 Apr; 90(4):543-9. PubMed ID: 9176107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation.
    Reddy J; Chastagner P; Fiette L; Liu X; Thèze J
    Int Immunol; 2001 Feb; 13(2):135-47. PubMed ID: 11157847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes.
    Suda T; Murray R; Guidos C; Zlotnik A
    J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes.
    Nishimura H; Agata Y; Kawasaki A; Sato M; Imamura S; Minato N; Yagita H; Nakano T; Honjo T
    Int Immunol; 1996 May; 8(5):773-80. PubMed ID: 8671666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK activity regulates negative selection of immature CD4+CD8+ thymocytes.
    Bommhardt U; Scheuring Y; Bickel C; Zamoyska R; Hünig T
    J Immunol; 2000 Mar; 164(5):2326-37. PubMed ID: 10679067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturation versus death of developing double-positive thymocytes reflects competing effects on Bcl-2 expression and can be regulated by the intensity of CD28 costimulation.
    McKean DJ; Huntoon CJ; Bell MP; Tai X; Sharrow S; Hedin KE; Conley A; Singer A
    J Immunol; 2001 Mar; 166(5):3468-75. PubMed ID: 11207305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.
    Blank C; Brown I; Marks R; Nishimura H; Honjo T; Gajewski TF
    J Immunol; 2003 Nov; 171(9):4574-81. PubMed ID: 14568931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Bim by TCR signals in CD4/CD8 double-positive thymocytes.
    Bunin A; Khwaja FW; Kersh GJ
    J Immunol; 2005 Aug; 175(3):1532-9. PubMed ID: 16034091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CTLA-4 in the activation of single- and double-positive thymocytes.
    Kwon H; Jun HS; Khil LY; Yoon JW
    J Immunol; 2004 Dec; 173(11):6645-53. PubMed ID: 15557155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.
    Yasutomo K; Lucas B; Germain RN
    J Immunol; 2000 Sep; 165(6):3015-22. PubMed ID: 10975810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.